Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    February 2017
  1. RONCHETTI L, Melucci E, De Nicola F, Goeman F, et al
    DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30668.
    PubMed     Text format     Abstract available


  2. MUHAMMAD JS, Nanjo S, Ando T, Yamashita S, et al
    Autophagy Impairment by Helicobacter pylori-induced Methylation Silencing of MAP1LC3Av1 Promotes Gastric Carcinogenesis.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30657.
    PubMed     Text format     Abstract available


    December 2016
  3. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available


    October 2016
  4. WANG T, Cai H, Sasazuki S, Tsugane S, et al
    Fruit and Vegetable Consumption, Helicobacter pylori Antibodies, and Gastric Cancer Risk: A Pooled Analysis of Prospective Studies in China, Japan and Korea.
    Int J Cancer. 2016 Oct 19. doi: 10.1002/ijc.30477.
    PubMed     Text format     Abstract available


  5. NAGASE H, Takeoka T, Urakawa S, Morimoto-Okazawa A, et al
    ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.
    Int J Cancer. 2016 Oct 18. doi: 10.1002/ijc.30475.
    PubMed     Text format     Abstract available


    August 2016
  6. XIA J, Huang N, Huang H, Sun L, et al
    Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1.
    Int J Cancer. 2016 Aug 16. doi: 10.1002/ijc.30381.
    PubMed     Text format     Abstract available


  7. NISHIKAWA K, Takahashi T, Takaishi H, Miki A, et al
    Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced or recurrent gastric cancer (JFMC45-1102).
    Int J Cancer. 2016 Aug 13. doi: 10.1002/ijc.30383.
    PubMed     Text format     Abstract available


    July 2016
  8. KANDA M, Tanaka C, Kobayashi D, Tanaka H, et al
    Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.
    Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30286.
    PubMed     Text format     Abstract available


    April 2016
  9. IGUCHI M, Kato J, Fukatsu K, Yamamoto Y, et al
    Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30145.
    PubMed     Text format     Abstract available


  10. HIDAKA A, Sasazuki S, Matsuo K, Ito H, et al
    CYP1A1, GSTM1, and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
    Int J Cancer. 2016 Apr 7. doi: 10.1002/ijc.30130.
    PubMed     Text format     Abstract available


    March 2016
  11. LIERSCH-LOHN B, Slavova N, Buhr HJ, Bennani-Baiti IM, et al
    Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
    Int J Cancer. 2016;138:1220-31.
    PubMed     Text format     Abstract available


    February 2016
  12. WANG Z, Butler LM, Wu AH, Koh WP, et al
    Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30024.
    PubMed     Text format     Abstract available


    January 2016
  13. FANG WL, Lan YT, Huang KH, Liu CA, et al
    Clinical significance of circulating plasma DNA in gastric cancer.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30018.
    PubMed     Text format     Abstract available


  14. HUI KF, Cheung AK, Choi CK, Yeung PL, et al
    Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Int J Cancer. 2016;138:125-36.
    PubMed     Text format     Abstract available


    November 2015
  15. SUGIMOTO R, Sugai T, Habano W, Endoh M, et al
    Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29916.
    PubMed     Text format     Abstract available


    October 2015
  16. DONG W, Qin G, Shen R
    Rab11-FIP2 promotes the metastasis of gastric cancer cells.
    Int J Cancer. 2015 Oct 26. doi: 10.1002/ijc.29899.
    PubMed     Text format     Abstract available


  17. MURPHY G, Freedman ND, Michel A, Fan JH, et al
    Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Int J Cancer. 2015;137:1938-46.
    PubMed     Text format     Abstract available


    September 2015
  18. IZUMI D, Ishimoto T, Miyake K, Sugihara H, et al
    CXCL12/CXCR4 Activation by Cancer-Associated Fibroblasts Promotes Integrin ss1 Clustering and Invasiveness in Gastric Cancer.
    Int J Cancer. 2015 Sep 28. doi: 10.1002/ijc.29864.
    PubMed     Text format     Abstract available


    August 2015
  19. WADA K, Tsuji M, Tamura T, Konishi K, et al
    Soy isoflavone intake and stomach cancer risk in Japan: From the Takayama study.
    Int J Cancer. 2015;137:885-92.
    PubMed     Text format     Abstract available


  20. KANDA M, Shimizu D, Fujii T, Sueoka S, et al
    Function and diagnostic value of Anosmin-1 in gastric cancer progression.
    Int J Cancer. 2015 Aug 13. doi: 10.1002/ijc.29803.
    PubMed     Text format     Abstract available


  21. STEFFEN A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, et al
    General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2015;137:646-57.
    PubMed     Text format     Abstract available


  22. BUCKLAND G, Travier N, Huerta JM, Bueno-de-Mesquita HB, et al
    Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study.
    Int J Cancer. 2015;137:598-606.
    PubMed     Text format     Abstract available


  23. SCHULZ C, Kullmann F, Kunzmann V, Fuchs M, et al
    NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Int J Cancer. 2015;137:678-85.
    PubMed     Text format     Abstract available


    July 2015
  24. CHARVAT H, Sasazuki S, Inoue M, Iwasaki M, et al
    Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC Study Cohort II.
    Int J Cancer. 2015 Jul 28. doi: 10.1002/ijc.29705.
    PubMed     Text format     Abstract available


  25. CAMARGO MC, Beltran M, Conde-Glez CJ, Harris PR, et al
    Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29678.
    PubMed     Text format     Abstract available


  26. FONSECA-NUNES A, Agudo A, Aranda N, Arija V, et al
    Body iron status and gastric cancer risk in the EURGAST study.
    Int J Cancer. 2015 Jul 1. doi: 10.1002/ijc.29669.
    PubMed     Text format     Abstract available


    June 2015
  27. GUO Y, Zhou J, Huang A, Li J, et al
    Spatially defined microsatellite analysis reveals extensive genetic mosaicism and clonal complexity in intestinal metaplastic glands.
    Int J Cancer. 2015;136:2973-9.
    PubMed     Text format     Abstract available


  28. ISHIMOTO T, Baba H, Izumi D, Sugihara H, et al
    Current perspectives towards the identification of key players in gastric cancer microRNA dysregulation.
    Int J Cancer. 2015 Jun 4. doi: 10.1002/ijc.29627.
    PubMed     Text format     Abstract available


    May 2015
  29. YE F, Tang C, Shi W, Qian J, et al
    A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced by Helicobacter pylori lipopolysaccharide.
    Int J Cancer. 2015;136:2120-31.
    PubMed     Text format     Abstract available


    April 2015
  30. LI Z, Zou X, Xie L, Chen H, et al
    Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Int J Cancer. 2015;136:1636-45.
    PubMed     Text format     Abstract available


    March 2015
  31. WON CHUNG H, Jang S, Kim H, Lim JB, et al
    Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer.
    Int J Cancer. 2015 Mar 27. doi: 10.1002/ijc.29539.
    PubMed     Text format     Abstract available


  32. QI P, Xu MD, Shen XH, Ni SJ, et al
    Reciprocal repression between TUSC7 and miR-23b in gastric cancer.
    Int J Cancer. 2015 Mar 12. doi: 10.1002/ijc.29516.
    PubMed     Text format     Abstract available


    February 2015
  33. GARCIA-GONZALEZ MA, Bujanda L, Quintero E, Santolaria S, et al
    Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.
    Int J Cancer. 2015 Feb 26. doi: 10.1002/ijc.29500.
    PubMed     Text format     Abstract available


  34. DONG L, Qi P, Xu MD, Ni SJ, et al
    Circulating CUDR, LSINCT-5 and PTENP1 long non-coding rnas in sera distinguish patients with gastric cancer from healthy controls.
    Int J Cancer. 2015 Feb 18. doi: 10.1002/ijc.29484.
    PubMed     Text format     Abstract available


  35. CHO SJ, Kook MC, Lee JH, Shin JY, et al
    Peroxisome proliferator-activated receptor gamma upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
    Int J Cancer. 2015;136:810-20.
    PubMed     Text format     Abstract available


    January 2015
  36. TOYOSHIMA K, Hayashi A, Kashiwagi M, Hayashi N, et al
    Analysis of circulating tumor cells derived from advanced gastric cancer.
    Int J Cancer. 2015 Jan 27. doi: 10.1002/ijc.29455.
    PubMed     Text format     Abstract available


  37. KIM SY, Choi YY, An JY, Shin HB, et al
    The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.
    Int J Cancer. 2015 Jan 22. doi: 10.1002/ijc.29449.
    PubMed     Text format     Abstract available


  38. TU H, Sun L, Dong X, Gong Y, et al
    Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
    Int J Cancer. 2015;136:425-34.
    PubMed     Text format     Abstract available


  39. MINAMI Y, Kawai M, Fujiya T, Suzuki M, et al
    Family history, body mass index and survival in Japanese patients with stomach cancer: a prospective study.
    Int J Cancer. 2015;136:411-24.
    PubMed     Text format     Abstract available


    December 2014
  40. FUKUOKA T, Yashiro M, Kinoshita H, Morisaki T, et al
    Prostaglandin D synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARgamma
    Int J Cancer. 2014 Dec 16. doi: 10.1002/ijc.29392.
    PubMed     Text format     Abstract available


  41. IV SANTALIZ-RUIZ LE, Xie X, Old M, Teknos TN, et al
    Emerging role of nanog in tumorigenesis and cancer stem cells.
    Int J Cancer. 2014;135:2741-8.
    PubMed     Text format     Abstract available


    November 2014
  42. CUI J, Yin Y, Ma Q, Wang G, et al
    Comprehensive Characterization of the Genomic Alterations in Human Gastric Cancer.
    Int J Cancer. 2014 Nov 24. doi: 10.1002/ijc.29352.
    PubMed     Text format     Abstract available


  43. GENTILE A, Lazzari L, Benvenuti S, Trusolino L, et al
    The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.
    Int J Cancer. 2014;135:2305-16.
    PubMed     Text format     Abstract available


    June 2014
  44. VEDELD HM, Andresen K, Andrassy Eilertsen I, Nesbakken A, et al
    The novel colorectal cancer biomarkers CDO1, ZSCAN18, and ZNF331 are frequently methylated across gastrointestinal cancers.
    Int J Cancer. 2014 Jun 20. doi: 10.1002/ijc.29039.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: